INTRODUCTIONVascular calcification has been found to be associated with three‐ to fourfold increased risk of cardiovascular (CV) morbidity and mortality. Calcium deposition in the coronary arteries, also referred to as coronary artery calcium (CAC), and its progression has been associated with future coronary heart disease (CHD) events, including myocardial infarction (MI). Promotion of vascular calcification has been attributed to the de‐differentiation of vascular smooth muscle cells (VSMCs) into osteoblast‐like phenotype. A number of studies have demonstrated the presence of bone‐associated proteins, such as osteopontin, osteocalcin, bone morphogenic protein (BMP)‐2, osteonectin, and matrix Gla protein (MGP) in human calcified, atherosclerotic plaques. In this study, we aimed to evaluate whether serum levels of BMP‐4 and MGP differed in patients who were found to have normal epicardial coronary arteries or a culprit lesion in the coronary angiography leading to acute coronary syndrome (ACS).MATERIALS AND METHODSStudy populationPatients admitted to emergency department with the diagnosis of ACS who underwent primary percutaneous coronary intervention (PCI) between October 2015 and April 2016 were consecutively recruited as the patient group. Age and gender‐matched subjects who underwent coronary angiography following non‐invasive ischemia assessment made the control group. Exclusion criteria were determined as a prior diagnosis of chronic kidney
Journal of Clinical Laboratory Analysis – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera